liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Corporate Governance in Pharmaceutical Industry: The case of TAPIC Pharmaceutical Group
Linköping University, Department of Management and Engineering, Industrial Marketing and Industrial Economics. Linköping University, The Institute of Technology. (Internationalization)
Linköping University, Department of Management and Engineering, Industrial Marketing and Industrial Economics. Linköping University, The Institute of Technology.
Tamin Active Pharmaceutical Ingredients Investment Company (TAPIC). (internationalization- MBA ProMA)
Tamin Active Pharmaceutical Ingredients Investment Company (TAPIC). (Internationalization - MBA ProMA)
2010 (English)In: Proceedings of the 6th European Conference on Management Leadership and Governance, Reading, UK: Academic Conferences Limited, 2010, 83-93 p.Conference paper, Published paper (Other academic)
Abstract [en]

Pharmaceutical industry plays a strategic role in economy of Iran. Corporate governance, in pharmaceutical companies as the very core of an organization, and the driving force of corporate leadership, plays a significant role in business success and overall productivity of the firms. As yet, the characteristics, factors causing success and failure of core governance in Iranian pharmaceutical industry have remained unsearched. Furthermore, the applicability of western theories and models to the traditional societies such as Iran are largely unknown. This study is an attempt to explore the pattern of corporate governance and firm performance in Iranian pharmaceutical industry and suggests an alternative good governance model suitable to apply to less developed countries (LDC) pharmaceutical industry, with emphasis on Iranian context.

Place, publisher, year, edition, pages
Reading, UK: Academic Conferences Limited, 2010. 83-93 p.
Keyword [en]
Corporate cogernenace, factors influencing the board, Pharmaceutical indusutry, Iran
National Category
Business Administration
Identifiers
URN: urn:nbn:se:liu:diva-73482ISI: 000290938700010ISBN: 978-1-1906638-81-8 (print)OAI: oai:DiVA.org:liu-73482DiVA: diva2:473027
Conference
6th European Conference on Management, Leadership and Governance (ECMLG 2010), Wroclaw, Poland, 28-29 October 2010
Projects
ProMA
Available from: 2012-01-04 Created: 2012-01-04 Last updated: 2016-05-11Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Dadfar, HosseinBrege, Staffan

Search in DiVA

By author/editor
Dadfar, HosseinBrege, Staffan
By organisation
Industrial Marketing and Industrial EconomicsThe Institute of Technology
Business Administration

Search outside of DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 220 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf